Skip to main content
. Author manuscript; available in PMC: 2018 Oct 2.
Published in final edited form as: Mol Pharm. 2017 Sep 6;14(10):3239–3247. doi: 10.1021/acs.molpharmaceut.7b00216

Figure 1.

Figure 1

The binding and immunoreactivity of YY146 and NOTA-YY146 in lung cancer cell lines was determined via flow cytometry. H460 (CD146-High) and H358 (CD146-Low) cells were incubated PBS (control; blue), 2° antibody alone (green), 5 μg/mL YY146 (purple), 5 μg/mL NOTA-YY146 (pink), 25 μg/mL YY146 (cyan), or 25 μg/mL NOTA-YY146 (orange).